Conference - Philadelphia, PA, United States
The Targeting Alzheimer's Disease conference provides an opportunity to learn new methods, network with experts in Alzheimer’s disease research and have access to the latest technology in translational research, imaging, biomarker development, and target validation.
The central quest of research on Alzheimer’s disease is to identify precisely what process first interferes with episodic declarative memory and then prevent that process. Soluble Aß oligomers isolated directly from AD cortex impair synaptic form and function and induce tau hyperphosphorylation and neuritic dystrophy. Based on this knowledge, attempts to develop effective A-lowering agents have brought us to human trials that have provided preliminary evidence of apparent cognitive and biomarker benefit.
KEYNOTE PRESENTATION
Dennis J. Selkoe, M.D., Vincent and Stella Coates Professor of Neurologic Diseases, Harvard Medical School; Co-Director, Center for Neurologic Diseases, Brigham and Women’s Hospital
(Photo courtesy of http://www.worldpharmacongress.com/alz/)
Tuesday, June 5, 2012 to Wednesday, June 6, 2012 (8:00 am-6:00 pm)
Philadelphia, PA
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
